BIO-BBIO-BNYSE
Loading
Cash Generation ExpandingExpanding
Percentile Rank86
3Y CAGR+67.1%
5Y CAGR-4.7%
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

3Y CAGR
+67.1%/yr
vs -15.3%/yr prior
5Y CAGR
-4.7%/yr
Recent acceleration
Acceleration
+82.4pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$374.60M+40.7%
2024$266.20M+22.0%
2023$218.26M+171.8%
2022$80.29M-85.0%
2021$535.72M+12.4%
2020$476.41M+32.6%
2019$359.37M+130.9%
2018$155.67M+1516.4%
2017$-10.99M-114.8%
2016$74.50M-